NCT07219251Recruiting
Engagement of Veterans With Lung Cancer
Engagement of Veterans With Lung Cancer (EVLC)
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 194 (estimated)
- First submitted
- 2 Oct 2025
- Start date
- 27 Feb 2026
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Palo Alto Veterans Institute for Research
- Diseases
- Lung cancer
- NCT number
- NCT07219251
What you commit to
- Study type: Interventional
- Planned participants: 194
- From 27 Feb 2026 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- actively receiving hospice care
Other
- no capacity to consent;
Who the study is looking for
- Veteran patients with diagnosis of any stage of lung cancer;
- 18 years of age or older;
- English- or Spanish-speaking;
- can self-administer questionnaires in English or Spanish;
- valid telephone number;
- receiving oncology care at participating sites;
- currently newly diagnosed or receiving or having completed systemic anti-cancer therapy and/or radiation therapy within 12 months, defined as oral, injection, or intravenous therapy (chemotherapy, targeted therapy, or immunotherapy)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Veterans Affairs Palo Alto Health Care System (VAPAHCS) Coordinator of this site? Confirm its status | Palo Alto | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.